On November 30, 2020 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported that it will host a webcast on Monday, December 7, 2020 at 4:30pm EST (Press release, Regeneron, NOV 30, 2020, View Source [SID1234572005]). Management will discuss data presented at the American Society of Hematology (ASH) (Free ASH Whitepaper) 2020 Annual Meeting as well as provide updates on the Company’s broader oncology and hematology portfolio.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information
To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7442859. A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at View Source A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days.